EMA ‘Yes’ For Pegfilgrastim Biosimilars Spells End For Neulasta’s EU Stronghold

SC1807_Knight_1039720336_1200.jpg
Amgen's EU pegfilgrastim stronghold faces biosimilar attack • Source: Shutterstock

More from Business

More from Scrip